(0.16%) 5 139.50 points
(0.11%) 38 483 points
(0.25%) 17 891 points
(-0.23%) $83.66
(0.94%) $1.941
(0.26%) $2 353.40
(0.54%) $27.68
(1.78%) $938.55
(-0.19%) $0.933
(-0.31%) $10.99
(-0.31%) $0.798
(1.20%) $92.97
-1.07% HKD 3.71
Live Chart Being Loaded With Signals
Golden Throat Holdings Group Company Limited, an investment holding company, manufactures and sells pharmaceutical, healthcare food, and other products in the People's Republic of China...
Stats | |
---|---|
Tagesvolumen | 117 000 |
Durchschnittsvolumen | 243 688 |
Marktkapitalisierung | 2.74B |
EPS | HKD0 ( 2024-03-28 ) |
Last Dividend | HKD0.360 ( 2023-06-16 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 7.27 |
ATR14 | HKD0.0110 (0.30%) |
Golden Throat Holdings Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Golden Throat Holdings Finanzdaten
Annual | 2023 |
Umsatz: | HKD961.38M |
Bruttogewinn: | HKD697.72M (72.57 %) |
EPS: | HKD0.340 |
FY | 2023 |
Umsatz: | HKD961.38M |
Bruttogewinn: | HKD697.72M (72.57 %) |
EPS: | HKD0.340 |
FY | 2022 |
Umsatz: | HKD992.01M |
Bruttogewinn: | HKD720.92M (72.67 %) |
EPS: | HKD0.380 |
FY | 2021 |
Umsatz: | HKD820.54M |
Bruttogewinn: | HKD577.74M (70.41 %) |
EPS: | HKD0.250 |
Financial Reports:
No articles found.
Golden Throat Holdings Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.360 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.0600 | 2016-05-26 |
Last Dividend | HKD0.360 | 2023-06-16 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 10 | -- |
Total Paid Out | HKD1.140 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.61 | -- |
Div. Sustainability Score | 8.35 | |
Div.Growth Potential Score | 5.03 | |
Div. Directional Score | 6.69 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
2289.HK | Ex Dividend Junior | 2023-06-29 | Annually | 0 | 0.00% | |
1277.HK | Ex Dividend Knight | 2023-10-09 | Semi-Annually | 0 | 0.00% | |
0335.HK | Ex Dividend Knight | 2023-09-04 | Annually | 0 | 0.00% | |
6069.HK | Ex Dividend Junior | 2023-06-28 | Annually | 0 | 0.00% | |
1836.HK | Ex Dividend Knight | 2023-09-06 | Annually | 0 | 0.00% | |
0861.HK | Ex Dividend Junior | 2023-09-14 | Semi-Annually | 0 | 0.00% | |
0012.HK | Ex Dividend Knight | 2023-09-04 | Semi-Annually | 0 | 0.00% | |
2611.HK | Ex Dividend Junior | 2023-06-09 | Annually | 0 | 0.00% | |
1402.HK | Ex Dividend Junior | 2023-08-10 | Sporadic | 0 | 0.00% | |
0480.HK | Ex Dividend Knight | 2023-08-28 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.260 | 1.500 | 4.80 | 7.19 | [0 - 0.5] |
returnOnAssetsTTM | 0.109 | 1.200 | 6.37 | 7.65 | [0 - 0.3] |
returnOnEquityTTM | 0.168 | 1.500 | 9.25 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.972 | -1.000 | 0.279 | -0.279 | [0 - 1] |
currentRatioTTM | 2.57 | 0.800 | 2.14 | 1.715 | [1 - 3] |
quickRatioTTM | 2.11 | 0.800 | 2.29 | 1.833 | [0.8 - 2.5] |
cashRatioTTM | 1.460 | 1.500 | 3.00 | 4.50 | [0.2 - 2] |
debtRatioTTM | 0.179 | -1.500 | 7.01 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.348 | 2.00 | 9.88 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.337 | 2.00 | 9.83 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.266 | -1.500 | 8.94 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.726 | 1.000 | 1.238 | 1.238 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.350 | 1.000 | 4.99 | 4.99 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.624 | 1.000 | 7.65 | 7.65 | [0.2 - 2] |
assetTurnoverTTM | 0.418 | 0.800 | -0.546 | -0.436 | [0.5 - 2] |
Total Score | 8.35 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 10.17 | 1.000 | 9.07 | 0 | [1 - 100] |
returnOnEquityTTM | 0.168 | 2.50 | 9.51 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.337 | 2.00 | 9.89 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 10.46 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.348 | 2.00 | 9.88 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.972 | 1.500 | 0.279 | -0.279 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.268 | 1.000 | 5.81 | 0 | [0.1 - 0.5] |
Total Score | 5.03 |
Golden Throat Holdings
Golden Throat Holdings Group Company Limited, an investment holding company, manufactures and sells pharmaceutical, healthcare food, and other products in the People's Republic of China. It offers Golden Throat lozenges over-the-counter medicine to relive symptoms of sore and dry throat, and hoarse voice caused by acute pharyngitis. It also provides Golden Throat lozenge series products that include Dule lozenges and sugar-free Dule lozenges in various flavors, such as orange, fructus momordicae, chrysanthemum, American ginseng, and hawthorn; Yinxingye tablet, which is designed to facilitate blood circulation, remove blood stasis, and dredge energy channels; and herbal vegetable beverages for soothing voice and relieving sore throats. The company also exports its products to the United States, Canada, Russia, the European Union, Australia, Southeast Asia, the Middle East, Mexico, and Africa. Golden Throat Holdings Group Company Limited was founded in 1956 and is headquartered in Liuzhou, the People's Republic of China.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.